A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/16/2002	EP1248636A1 Dextrin containing compositions for prevention of adhesions
10/16/2002	EP1248635A1 Antisense modulation of glycogen synthase kinase 3 alpha expression
10/16/2002	EP1248633A1 Antisense modulation of glycogen synthase kinase 3 beta expression
10/16/2002	EP1248632A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain
10/16/2002	EP1248627A2 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action
10/16/2002	EP1248626A2 Pharmaceutical compositions containing steroidal structures and uses thereof
10/16/2002	EP1248625A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors
10/16/2002	EP1248619A1 Amorphous paroxetine compositon
10/16/2002	EP1248618A1 Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl
10/16/2002	EP1248613A1 Clonidine preparations
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP1248610A2 Use of at least a fatty ester for preparing a composition designed to inhibit 5-alpha-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
10/16/2002	EP1248609A1 Method of treating benign forgetfulness
10/16/2002	EP1248606A1 Use of fumaric acid derivatives for treating mitochondrial diseases
10/16/2002	EP1248604A2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
10/16/2002	EP1248600A1 Improved pharmaceutical formulations
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1248517A2 Clonal propagation of primate offspring by embryo splitting
10/16/2002	EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/16/2002	EP1100528B1 Use of novel agents inducing cell death in synergy with interferons
10/16/2002	EP0991653B1 Novel compounds
10/16/2002	EP0944596B1 1-acryloylindoline derivatives and their use as prodrugs of anticancer agents
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002	EP0891365B1 Benzoxazines for enhancing synaptic responses
10/16/2002	EP0877605B1 Solid instant-release forms of administration and process for producing the same
10/16/2002	EP0868429B1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/16/2002	EP0831919B1 Method for pharmaceutical delivery by gene therapy
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/16/2002	EP0763033B1 Imidazole derivatives and processes for the preparation thereof
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	EP0637976B2 Medicament for disinfection of the oral cavity
10/16/2002	CN1375058A Method and device for detecting and insolating pharmacological compounds being contained in substance mixtures
10/16/2002	CN1374969A FAP-activated anti-tumor compounds
10/16/2002	CN1374966A 嘌呤衍生物 Purine derivatives
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374956A 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof and their use as anticonvulsants
10/16/2002	CN1374954A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374950A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/16/2002	CN1374949A 毒蕈碱拮抗剂 Muscarinic antagonist
10/16/2002	CN1374940A O-Anisamide derivatives
10/16/2002	CN1374865A Nociceptin receptor ORL-1 agonists for use in treating cough
10/16/2002	CN1374863A Bicyclic antagonists selective for the alpha beta integrin
10/16/2002	CN1374859A 药物粉剂 Drug powder
10/16/2002	CN1374857A Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins
10/16/2002	CN1374309A Application of cinidium general coumarin as psoriasis treating medicine
10/16/2002	CN1374305A Alkoxy derivative of safrole oxide 2-alkoxy-piperonyl ethanol and its prepn and application
10/16/2002	CN1374128A Jiudanhuanxincao herb capsule
10/16/2002	CN1374118A Chinese medicine for treating ache tendon and vessel and numb limbs and its prepn process
10/16/2002	CN1374114A New prepn process of Lideri as one traditional Mongoliam medicine
10/16/2002	CN1374112A New prepn process of Zhuanglong as one traditional Mongolian medicine
10/16/2002	CN1374111A New prepn process of Manu as one traditional Mongolian medicine
10/16/2002	CN1374086A Neutrocyte functional inhibitor
10/16/2002	CN1374084A Lauryl piperazine, lauryl diethanolamine and the application of their derivatives in extracorporeal marrow purification
10/16/2002	CN1374082A Use of glycogen sulphofoenzyme inhibitor
10/16/2002	CN1374081A Application of safrole oxide in the growth and death of vascular endothelial cell
10/16/2002	CN1092643C Certain aminomethyl phenylidazole derivatives, for intensifying memory
10/16/2002	CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002	CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002	CN1092521C Medicine linded in health care shoes sole or insole
10/16/2002	CA2406401A1 Process for preparation of sulfonamide derivatives and crystals thereof
10/16/2002	CA2406161A1 2-guanidino-4-arylquinazolines as nhe-3 inhibitors
10/15/2002	USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002	US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002	US6465660 Isoindoloindolone compounds
10/15/2002	US6465651 Process and intermediates for growth hormone secretagogues
10/15/2002	US6465519 Uses of modafinil and its D/L enantiomers
10/15/2002	US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002	US6465516 Increasing nitric oxide production by administering inhibitors of hmg-coa-reductase; treatment of diseases related to endothelial dysfunction
10/15/2002	US6465512 Leukemic cell growth inhibiting method
10/15/2002	US6465509 Pyrones as inhibitors of cyclooxygenase-2
10/15/2002	US6465507 Antitumor agents
10/15/2002	US6465503 Selective urokinase inhibitors
10/15/2002	US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002	US6465497 Arylthiazolidinedione derivatives
10/15/2002	US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002	US6465487 Inhibition of membrane-associated viral replication
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
10/15/2002	US6465455 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/15/2002	US6465453 Azepine derivatives having effects on serotonin related systems
10/15/2002	US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002	US6465441 Screening method for modulation of human mast cell activation
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002	US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002	US6465421 Promoting the growth of body and/or head hair and/or combatting the loss of such hair via cyclooxygenase treatment, as well as, contrariwise, retarding and/or preventing the growth of body/cranial hair via lipoxygenase treatment
10/15/2002	US6465248 Methods for producing and preparing cells for cell therapy
10/15/2002	US6465231 GSK3 polypeptides
10/15/2002	US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002	US6465008 For therapy of tumors
10/15/2002	US6465007 Gene therapy using absorption enhancers or tight junction disrupters; transfection of a biologically active molecule by a cationic amphiphile: biologically active molecule complex or other lipid or viral or nonviral vectors; cystic fibrosis
10/15/2002	US6465003 Drug delivery

1 ... 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 ... 1564